These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 22082538

  • 1. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M, Napoli A, Zaccagna F, Cartocci G, Saba L, Menichini G, Cavallo Marincola B, Marotta E, Di Mare L, Catalano C, Passariello R.
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [Abstract] [Full Text] [Related]

  • 2. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience.
    Fraioli F, Anzidei M, Zaccagna F, Mennini ML, Serra G, Gori B, Longo F, Catalano C, Passariello R.
    Radiology; 2011 May; 259(2):574-82. PubMed ID: 21357523
    [Abstract] [Full Text] [Related]

  • 3. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    Granata V, Fusco R, Catalano O, Filice S, Amato DM, Nasti G, Avallone A, Izzo F, Petrillo A.
    PLoS One; 2015 May; 10(11):e0142876. PubMed ID: 26566221
    [Abstract] [Full Text] [Related]

  • 4. Correlation between response to chemotherapy with concomitant bevacizumab for hepatic metastasis of colorectal cancer and degree of enhancement using contrast-enhanced computed tomography.
    Osawa G, Yoshimatsu K, Yokomizo H, Okayama S, Sagawa M, Naritaka Y.
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):209-15. PubMed ID: 23670642
    [Abstract] [Full Text] [Related]

  • 5. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.
    Chung WS, Park MS, Shin SJ, Baek SE, Kim YE, Choi JY, Kim MJ.
    AJR Am J Roentgenol; 2012 Oct; 199(4):809-15. PubMed ID: 22997372
    [Abstract] [Full Text] [Related]

  • 6. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F.
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [Abstract] [Full Text] [Related]

  • 7. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
    Matsushima S, Sato T, Nishiofuku H, Sato Y, Murata S, Kinosada Y, Era S, Inaba Y.
    Clin Imaging; 2017 Dec; 41():1-6. PubMed ID: 27721090
    [Abstract] [Full Text] [Related]

  • 8. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
    Kim JH, Joo I, Kim TY, Han SW, Kim YJ, Lee JM, Han JK.
    AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
    [Abstract] [Full Text] [Related]

  • 9. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
    Fraioli F, Anzidei M, Serra G, Liberali S, Fiorelli A, Zaccagna F, Longo F, Anile M, Catalano C.
    Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
    [Abstract] [Full Text] [Related]

  • 10. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H, Fischer SE, Moulton CA, Karbhase G, Menezes RJ, Gallinger S, Jhaveri KS.
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC, Simon B, Luetkens JA, Träber F, Meyer C, Schmeel LC, Sabet A, Ezziddin S, Schild HH, Hadizadeh DR.
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [Abstract] [Full Text] [Related]

  • 12. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).
    Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV.
    Invest Radiol; 2012 Jan; 47(1):11-7. PubMed ID: 21512396
    [Abstract] [Full Text] [Related]

  • 13. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
    Marugami N, Tanaka T, Kitano S, Hirohashi S, Nishiofuku H, Takahashi A, Sakaguchi H, Matsuoka M, Otsuji T, Takahama J, Higashiura W, Kichikawa K.
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
    [Abstract] [Full Text] [Related]

  • 14. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A.
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [Abstract] [Full Text] [Related]

  • 15. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    Goshen E, Davidson T, Zwas ST, Aderka D.
    Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL, Zheng JP, Guo LW, Chen YT, Zeng H, Yao Z.
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [Abstract] [Full Text] [Related]

  • 17. Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT.
    Eiber M, Fingerle AA, Brügel M, Gaa J, Rummeny EJ, Holzapfel K.
    Eur J Radiol; 2012 Apr; 81(4):683-91. PubMed ID: 21316886
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.